Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0985B | Carbinoxamine, Blood |
1040B | Cetirizine, Blood |
1040SP | Cetirizine, Serum/Plasma |
1040U | Cetirizine, Urine |
1055B | Celecoxib, Blood |
1055SP | Celecoxib, Serum/Plasma |
1190B | Chlorpheniramine, Blood |
1190SP | Chlorpheniramine, Serum/Plasma |
1190U | Chlorpheniramine, Urine |
1306U | Codeine - Total (Conjugated/Unconjugated) Screen, Urine |
1380B | Cyanide, Blood |
1425B | Cyproheptadine, Blood |
1425SP | Cyproheptadine, Serum/Plasma |
1425U | Cyproheptadine, Urine |
3157U | Cotinine and Anabasine from Secondary Exposure, Urine |
8661B | Codeine and Metabolite - Free (Unconjugated), Blood |
8661SP | Codeine and Metabolite - Free (Unconjugated), Serum/Plasma |
8661U | Codeine and Metabolite - Total (Conjugated/Unconjugated), Urine |
9142B | Cyanide Screen, Blood |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |